Jan 24, 2019 ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on January 24, 2019 in the Florida Northern District ...
Utts et al v. Bristol-Myers Squibb Company et al, No. 1:2016cv05668 - Document 67 (S.D.N.Y. 2017) case opinion from the Southern District of New York US ...
Oct 27, 2017 ... Relators, former BMS employees, alleged in a qui tam suit that BMS and Otsuka engaged in a ... Relators allege that, despite those agreements, the companies continued to ... Ibanez v. Bristol-Myers Squibb Co., No. 16-3154 (6th Cir. 2017) ... 16-3154 U.S. ex rel. Ibanez v. Bristol-Myers Squibb, et. al. Page 2 ...
Feb 7, 2019 ... (all the claims) of United States Patent No. ... '239 Patent”) owned by Bristol- Myers Squibb Company ... Momenta Pharm., Inc. v. ... 311 et seq.
Feb 7, 2019 ... Momenta Pharmaceuticals, Inc. v, Bristol-Myers Squibb Co. ... and covered business method patent review) against a Petitioner (loss of patent ... partes review (IPR) brought by Momenta against all claims of U.S. Patent No.
All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.